featured
Vitiligo and Tumor Response in Metastatic Melanoma Treated With Pembrolizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
JAMA Dermatol 2015 Oct 21;[EPub Ahead of Print], C Hua, L Boussemart, C Mateus, E Routier, C Boutros, H Cazenave, R Viollet, M Thomas, S Roy, N Benannoune, G Tomasic, JC Soria, S Champiat, M Texier, E Lanoy, C RobertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.